Please login to the form below
7
Revenue 2017Prevnar 13
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Prevnar 13 was produced by Pfizer.
Keytruda doubles five-year survival rate in NSCLC
The checkpoint inhibitor also reduced the risk of death by 38% versus chemotherapy, with a median overall survival rate of 26.3 months for Keytruda compared to 13.4 months for
The flexible salesforce
The US has seen NPS rise by 16 percentage points for phone detailing and five for e-detailing, Spain’s increases have been seven and 13 points respectively and Italy has ... seen a 13-point increase for both channels.
FDA approves Sarepta rival NS Pharma’s Duchenne drug
This represents around 8% of the overall DMD population, while those with the exon 51 mutation account for around 13%.
The best work in healthcare communications shines at virtual Communiqué Awards
13. Excellence in Social Media Strategy. Sponsored by Evoke KYNE. Winner: Tackle TD: On the Sidelines by Havas SO for Bayer.
The search for treatments for Parkinson’s disease
The number of people living with Parkinson’s is predicted to rise to more than 13 million by 2040, underscoring the need to halt or at least slow down its destructive ... In Europe, the burden is immense, with the European Parkinson’s Disease
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- BMS eyes approval for second Opdivo combo in kidney cancer
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Bedrock Group
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
